论文信息 - mTOR Inhibitor RAD 001 ( Everolimus ) Has Antiangiogenic / Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor - 字舞流文

mTOR Inhibitor RAD 001 ( Everolimus ) Has Antiangiogenic / Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor

H. Lane | C. Schnell | J. Brueggen | J. Wood | T. O'reilly | S. Maira | A. Boulay | P. Allegrini | A. Littlewood-Evans | P. Sini | P. McSheehy | GeorgMartiny-Baron